Bone Marrow Transplantation - Table of Contents alert Volume 49 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 49, Issue 12 (December 2014) In this issue Obituary Editorial Review Original Articles Letters to the Editor Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement NEW LAB OFFERS: Exclusive deals on equipment and services Save time and money, check Marketplace first VISIT MARKETPLACE TODAY   Obituary Top John Leslie Fahey 1924–2014 R P Gale Bone Marrow Transplant 2014 49: 1453-1454; 10.1038/bmt.2014.240 Full Text Editorial Top A golden opportunity L Gazourian Bone Marrow Transplant 2014 49: 1455-1456; advance online publication, August 18, 2014; 10.1038/bmt.2014.185 Full Text Review Top Not too little, not too much—just right! (Better ways to give high dose melphalan) P J Shaw, C E Nath and H M Lazarus Bone Marrow Transplant 2014 49: 1457-1465; advance online publication, August 18, 2014; 10.1038/bmt.2014.186 Abstract | Full Text Original Articles Top ACUTE LEUKEMIA Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation J-H Yoon, H-J Kim, J-W Kim, Y-W Jeon, S-H Shin, S-E Lee, B-S Cho, K-S Eom, Y-J Kim, S Lee, C-K Min, S-G Cho, J-W Lee, W-S Min and C-W Park Bone Marrow Transplant 2014 49: 1466-1474; advance online publication, August 11, 2014; 10.1038/bmt.2014.180 Abstract | Full Text LYMPHOMA Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas L Castagna, S Bramanti, S Furst, L Giordano, R Crocchiolo, B Sarina, E Mauro, L Morabito, R Bouabdallah, D Coso, M Balzarotti, F Broussais, J El-Cheikh, C C Stella, E Brusamolino, D Blaise and A Santoro Bone Marrow Transplant 2014 49: 1475-1480; advance online publication, September 15, 2014; 10.1038/bmt.2014.197 Abstract | Full Text APLASTIC ANEMIA Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia Z Wang, X Zheng, H Yan, D li and H Wang Bone Marrow Transplant 2014 49: 1481-1485; advance online publication, August 18, 2014; 10.1038/bmt.2014.187 Abstract | Full Text GRAFT SOURCE Superselective intra-arterial umbilical cord blood administration to BM in experimental animals OPEN F Arnberg, J Lundberg, E Kenne, N Jaff, P Müller, S Nava, H Kaipe, O Ringdén and S Holmin Bone Marrow Transplant 2014 49: 1486-1491; advance online publication, September 8, 2014; 10.1038/bmt.2014.190 Abstract | Full Text Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen E Gomez, R Duléry, C Langlois, V Coiteux, L Terriou, L Magro, J Gauthier, E de Berranger, A Duhamel and I Yakoub-Agha Bone Marrow Transplant 2014 49: 1492-1497; advance online publication, September 15, 2014; 10.1038/bmt.2014.193 Abstract | Full Text CONDITIONING The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML P Hagen, J E Wagner, T E DeFor, M Dolan, M Arora, E Warlick, D Weisdorf and C G Brunstein Bone Marrow Transplant 2014 49: 1498-1504; advance online publication, September 22, 2014; 10.1038/bmt.2014.183 Abstract | Full Text TRANSPLANT TOXICITIES Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT S Fuji, K Takano, T Mori, T Eto, S Taniguchi, K Ohashi, H Sakamaki, Y Morishima, K Kato, K Miyamura, R Suzuki and T Fukuda Bone Marrow Transplant 2014 49: 1505-1512; advance online publication, August 11, 2014; 10.1038/bmt.2014.178 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD L M Curtis, L Grkovic, S A Mitchell, S M Steinberg, E W Cowen, M B Datiles, J Mays, C Bassim, G Joe, L E Comis, A Berger, D Avila, T Taylor, D Pulanic, K Cole, J Baruffaldi, D H Fowler, R E Gress and S Z Pavletic Bone Marrow Transplant 2014 49: 1513-1520; advance online publication, August 25, 2014; 10.1038/bmt.2014.188 Abstract | Full Text Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children J T Huang, C N Duncan, D Boyer, H Khosravi, L E Lehmann and A Saavedra Bone Marrow Transplant 2014 49: 1521-1527; advance online publication, September 22, 2014; 10.1038/bmt.2014.194 Abstract | Full Text INFECTIONS The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD J Uhm, N Hamad, F V Michelis, M Shanavas, J Kuruvilla, V Gupta, J H Lipton, H A Messner, M Seftel and D D Kim Bone Marrow Transplant 2014 49: 1528-1534; advance online publication, August 11, 2014; 10.1038/bmt.2014.181 Abstract | Full Text Letters to the Editor Top Administration of anti-thymocyte globulin: a comparison of two protocols A B Clemmons, M E Hartranft, V Kota, J Pantin, F T Awan, H Salman and A P Jillella Bone Marrow Transplant 2014 49: 1535-1537; advance online publication, August 4, 2014; 10.1038/bmt.2014.174 Full Text Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children D Zama, R Masetti, D M Cordelli, F Vendemini, L Giordano, G Milito, E Franzoni, F Porta, A Prete, R Rondelli and A Pession Bone Marrow Transplant 2014 49: 1538-1540; advance online publication, August 18, 2014; 10.1038/bmt.2014.182 Full Text Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation H Hägglund, M Remberger and O Ringden Bone Marrow Transplant 2014 49: 1541-1542; advance online publication, September 22, 2014; 10.1038/bmt.2014.184 Full Text Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma K Kato, Y Ohno, T Kamimura, H Kusumoto, T Tochigi, F Jinnouchi, K Kohno, T Kuriyama, H Henzan, K Takase, I Kawano, M Kadowaki, R Nawata, T Muta, T Eto, H Iawasaki, K Ohshima, T Miyamoto and K Akashi Bone Marrow Transplant 2014 49: 1543-1544; advance online publication, August 18, 2014; 10.1038/bmt.2014.189 Full Text Bortezomib/bendamustine/dexamethasone induced good PR in refractory relapse post auto-SCT with constitutive RAS activation due to V600E BRAF mutation C S Chim and K Y Wong Bone Marrow Transplant 2014 49: 1545-1547; advance online publication, August 18, 2014; 10.1038/bmt.2014.192 Full Text High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation N Nakano, A Kubota, M Tokunaga, M Tokunaga, T Itoyama, T Makino, S Takeuchi, Y Takatsuka and A Utsunomiya Bone Marrow Transplant 2014 49: 1548-1549; advance online publication, September 22, 2014; 10.1038/bmt.2014.204 Full Text Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation S Bhaskaran, R F Abu-Arja, G Abusin, L Cabral, K Nagle, S Ahuja, R Egler, K R Cooke and H M Lazarus Bone Marrow Transplant 2014 49: 1550-1551; advance online publication, September 22, 2014; 10.1038/bmt.2014.205 Full Text Corrigendum Top Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas L Castagna, S Bramanti, S Furst, L Giordano, R Crocchiolo, B Sarina, E Mauro, L Morabito, R Bouabdallah, D Coso, M Balzarotti, F Broussais, J El-Cheikh, C C Stella, E Brusamolino, D Blaise and A Santoro Bone Marrow Transplant 2014 49: 1552; 10.1038/bmt.2014.267 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.